TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 DKK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
203,226
|
205,647
|
179,106 |
| Financial expenses |
6,687
|
5,459
|
130,101 |
| Earnings before taxes |
-4,244
|
23,856
|
-87,920 |
| Total assets |
287,673
|
248,396
|
227,750 |
| Current assets |
112,453
|
102,768
|
100,127 |
| Current liabilities |
83,215
|
30,596
|
22,784 |
| Equity capital |
193,045
|
205,614
|
192,722 |
| - share capital |
31,327
|
33,064
|
31,373 |
| Employees (average) |
0
|
0 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.1%
|
82.8%
|
84.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
| Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
| Current ratio |
135.1%
|
335.9%
|
439.5% |
| Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
| Change turnover |
8,381
|
16,890
|
17,708 |
| Change turnover % |
4%
|
9%
|
11% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.